Novo Nordisk is about to discover the outcome of a gamble that investors hope can transform the drugmaker’s ailing outlook: can its weight loss drugs be used to treat Alzheimer’s?
Ahead of the results from two studies of thousands of people…
Continue Reading
News Source: www.ft.com

Leave a Reply